OVERVIEW
FOCUS AREA
17+ years in Client and Talent Leadership focused in the Life Science Industry.
Commercial strategy
Talent Management
Creating and growing business functions
Colm Coveney is an experienced commercial leader with over 17 years’ experience across Client Services, Engagement, Project Management, and Talent Management focused on the Life Science industry. Colm has led & co-ordinated the delivery and mobilization of small to large teams to support clients with various Quality, Compliance and Regulatory initiatives, including multi-site major remediation projects and strategic M&A assessments.
At ELIQUENT Life Sciences (formerly Validant), Colm has been instrumental in driving and expanding the European and RoW business through a focused commercial strategy and project optimization. He has held increasing management roles up to his current position as Company Director. Colm has led the identification, tendering and negotiating processes with C-level sponsors at the largest pharmaceutical and Medical device clients globally on critical Quality, Compliance and Regulatory projects. In his current position, Colm oversees all activity for the EU Headquarters including internal staff, external contractors, and vendor support.
Previous to ELIQUENT, Colm has created various Business Development, Talent Management and HR functions from from concept to successful operation.
-
EDUCATION:
BA (Hons) in Business, Munster Technological University
BA in Human Resources Management, Munster Technological UniversityCERTIFICATIONS:
H.R. Management & DevelopmentASSOCIATION MEMBERSHIPS:
CoChair of GAMP CoP (Ireland Affiliate) 2023-Present
ISPE, 2019Present -
PROFESSIONAL EXPERIENCE
ELIQUENT Life Sciences Director, Client Engagement
Stericycle (GxP Systems) Human Resource Manager
Oxford International Segment ManagerAREAS OF EXPERTISE
Client Services & Engagement
Commercial Strategy
Talent Management & Strategy
Stakeholder Management
Project Planning & Optimization
Ready for Regulatory Clarity?
Stay informed as the regulatory landscape evolves.
Subscribe to our blog to receive the latest updates on policy changes, FDA developments, and their impact on the life sciences industry.